NovaBridge Biosciences (NBP)
NASDAQ: NBP · Real-Time Price · USD
3.890
0.00 (0.00%)
At close: Jan 23, 2026, 4:00 PM EST
4.008
+0.118 (3.04%)
After-hours: Jan 23, 2026, 7:53 PM EST
NovaBridge Biosciences Employees
NovaBridge Biosciences had 32 employees as of December 31, 2024. The number of employees decreased by 188 or -85.45% compared to the previous year.
Employees
32
Change (1Y)
-188
Growth (1Y)
-85.45%
Revenue / Employee
n/a
Profits / Employee
-$822,688
Market Cap
448.48M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2024 | 32 | -188 | -85.45% |
| Dec 31, 2023 | 220 | -158 | -41.80% |
| Dec 31, 2021 | 378 | 150 | 65.79% |
| Dec 31, 2020 | 228 | 43 | 23.24% |
| Dec 31, 2019 | 185 | 51 | 38.06% |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Vanda Pharmaceuticals | 368 |
| ADC Therapeutics | 265 |
| 4D Molecular Therapeutics | 227 |
| Absci | 157 |
| Assembly Biosciences | 73 |
| PureTech Health | 56 |
| Contineum Therapeutics | 41 |
| Anavex Life Sciences | 34 |
NBP News
- 5 days ago - NovaBridge Announces Open Market Purchases by Executive Chairman, Fu Wei - GlobeNewsWire
- 19 days ago - NovaBridge Presents Positive Givastomig Dose Expansion Data from the Phase 1b Combination Study in Patients with 1L Metastatic Gastric Cancer - GlobeNewsWire
- 26 days ago - NovaBridge to Ring the Nasdaq Opening Bell on Friday, January 2, 2026 - GlobeNewsWire
- 6 weeks ago - NovaBridge Presents Positive Ragistomig Phase 1 Dose Expansion Data at ESMO-IO - GlobeNewsWire
- 7 weeks ago - NovaBridge Announces Presentation of Ragistomig Expanded Phase 1 Data at ESMO-IO - GlobeNewsWire
- 2 months ago - NovaBridge's Visara Subsidiary Appoints Distinguished Ophthalmology Leaders as Chief Medical Officer and Scientific Advisory Board Chair to Drive VIS-101 Forward - GlobeNewsWire
- 3 months ago - NovaBridge Subsidiary Visara Assigns Its Exclusive License to Everest Medicines for VIS-101 in Greater China and Certain Other Asian Countries - GlobeNewsWire
- 3 months ago - I-MAB (Nasdaq: IMAB) Transitions to NovaBridge Biosciences (Nasdaq: NBP) with Trading Effective October 30, 2025 New Brand and Logo to Reflect Strategic Transformation to a Global Biotech Platform - GlobeNewsWire